APOC3, apolipoprotein C3, 345

N. diseases: 153; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 GeneticVariation disease BEFREE By multivariable Cox analysis, concurrent fatty liver (HR 7.27, 95% confidence interval: 1.52-34.76; P = 0.013), age, cirrhosis, and APOC3 rs2854116 TC/CC genotype (HR 3.93, 95% confidence interval: 1.30-11.84; P = 0.013) were independent factors predicting HCC development. 27547913 2017
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 Biomarker disease BEFREE APOC3 neither exacerbated diet-induced adiposity nor aggravated the degree of steatosis in high fructose or high fat-fed APOC3-transgenic mice. 28115523 2017
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 GeneticVariation disease BEFREE The APOC3 rs2070666 A allele was linked to the fourth quartile of the controlled attenuation parameter values (OR 2.769, 95 % CI 1.002-7.651) in 131 subjects, and also linked to the significant histological steatosis (OR 4.986, 95 % CI 1.020-24.371), but neither to liver stiffness measurement values nor to hepatic histological activity and fibrosis in NAFLD patients. 27059980 2016
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 GeneticVariation disease BEFREE APOC3 polymorphisms had no effect on the development of steatosis and no influence on the PNPLA3 polymorphism. 23808989 2013
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 Biomarker disease BEFREE The impact of the APOC3 SNPs on fatty liver is small and depends on visceral obesity. 21829161 2012
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 GeneticVariation disease BEFREE The PNPLA3, but not the APOC3 rs2854116 SNP, was associated with fatty liver but not with triglyceride levels. 22105854 2012
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 AlteredExpression disease BEFREE However, APOC3 SNPs, alone or in combination, were not associated with insulin resistance, altered lipid levels, liver enzymes, and with liver damage (severity of steatosis, nonalcoholic steatohepatitis, and moderate/severe fibrosis) in Italian as well as in UK patients, and in the whole cohort. 21777557 2011
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.080 GeneticVariation disease BEFREE Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. 21663607 2011